FDA warns of another compounding pharmacy recall

by Matthew Perrone

BY MATTHEW PERRONE AP HEALTH WRITER WASHINGTON (AP) – The Food and Drug Administration is warning doctors that a compounding pharmacy is recalling dozens of lots of the Roche drug Avastin after receiving reports of eye infections among patients. The FDA said Wednesday that Clinical Specialties of Martinez, Ga. has received five reports of eye infections from physicians who used the drug to treat macular degeneration, a common vision disorder in seniors.
The compounding pharmacy is recalling 40 lots of Avastin distributed to doctors' offices in Georgia, Louisiana, South Carolina and Indiana since December 18, the FDA said in an online posting. Avastin is approved as a cancer drug, but it contains the same active ingredient as Lucentis, another Roche drug approved for macular degeneration. For years, compounding pharmacies have repackaged Avastin into small vials for use by eye doctors. Repackaged injections of Avastin cost about $50, compared with $2,000 for Lucentis. A call placed to Clinical Specialties' lead pharmacist, Austin Gore, was not immediately returned Wednesday. Swiss drugmaker Roche has tried to discourage doctors from using Avastin for such unapproved uses. The company points out that Lucentis was specifically tested and formulated for use in the eye, and its price reflects the cost of that research and development. However, groups like the American Academy of Ophthalmologists say there is no detectable difference in outcomes for patients. More than half the injections given for macular generation in the U.S. are Avastin, according to the group. Age-related macular degeneration is the most common cause of blindness among older Americans, affecting about 2 million people in the U.S. over age 50. The condition causes new blood vessels to grow in the eye and leak blood and fluid, damaging the retina and distorting vision. In recent weeks the FDA has stepped up inspections of compounding pharmacies across a dozen states after a fungal meningitis outbreak last year tied to compounded drugs. A tainted steroid distributed by a Massachusetts-based compounding pharmacy killed 50 people and has sickened more than 720 nationwide. Many of the cases involved a rare form of meningitis tied to fungus found in the New England Compounding Center's facilities. The company has been shut down since the outbreak was discovered in September. ---- © 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

More Local

County says Newnan House in compliance

The Newnan House Motel property on U.S. 29 North certainly isn’t anyone’s favorite Coweta landmark, but it’s fully complia ... Read More

Published on Sunday, June 16, 2013

Breaking News

Newnan Clerk Shot

A store clerk was injured in a shooting Saturday night, according to Newnan Police Department authorities. Just before 8:30 p.m.,at the Rus ... Read More

Published on Sunday, June 16, 2013

Moreland resident needs second kidney transplant

Unlike most retirees, Moreland resident Mike Mahoney does not have time or energy to enjoy his hobbies. He no longer tinkers with his bright ... Read More

Published on Sunday, June 16, 2013

Westmoreland supports data collection

The federal government’s data collection programs that were revealed by a contract employee for the National Security Agency on June 6 ... Read More

Published on Sunday, June 16, 2013

Newnan East Goodwill store opens Thursday

New employees are busy getting the new Newnan East Goodwill store and career center ready for its grand opening on Thursday.  There wil ... Read More

Published on Sunday, June 16, 2013